Biopharma companies at ASHG 2026
Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website
48 biopharma companies are at ASHG 2026 — 74 presentations on the program and 17 with a booth in the exhibit hall. Most represented: Regeneron (11 on the program), AstraZeneca (5 on the program), insitro, inc. (5 on the program). 19 of them have their own page in this guide. As of Sep 25, 2026.
Scientific focus
Top represented
Showing 1–8 of 48 organizations
| Organization | ASHG 2026 Attendance |
|---|---|
Regeneron Tarrytown, New York | 1 Employee · 1 Senior Manager, RGC · 1 Statistical Geneticist · 1 SVP and Chief Genomics and Data Sciences Officer |
Regeneron invents, develops, and commercializes medicines for serious diseases. Its work spans biologics, genetic medicines, and cell therapies.
| Booth Exhibiting at Booth 507 Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm Poster Wed Oct 21 2:30 pm ★ Reviewers’ Choice Systematic extraction of 4,434 imaging-derived phenotypes in 95,000 UK Biobank participants drives genetic discovery and validationComplex traitsLarge-scale biobanksRare variantsIdentification of disease genes Poster Wed Oct 21 2:30 pm ★ Reviewers’ Choice Exome-Wide Association Study of Type 2 Diabetes in 132,045 South Asians reveals Population-Enriched Protective Variants and Novel Therapeutic TargetsDiabetesLarge-scale biobanksRare variantsGenomics Poster Thu Oct 22 4:15 pm Loss-of-function variants in the DNA Mismatch Repair genes POLD1, PMS1 and FAN1 modify age at onset of motor symptoms in Huntington’s Disease. Exome/genome sequencingRare variantsNeurodegenerationTriplet and other repeats Poster Thu Oct 22 4:15 pm Poster Fri Oct 23 2:30 pm SBAT-REMETA: Combining rare-variant burden scores from summary statistics boosts gene discovery in multi-cohort studies Statistical geneticsRare variantsLarge-scale biobanksGenome-wide association study Poster Fri Oct 23 2:30 pm Whole-Exome Sequencing for Severe Inflammatory Bowel Disease: Genetic Architecture and Emerging Candidate Genes Clinical geneticsDiagnosticsGastrointestinal systemImmune system Poster Fri Oct 23 2:30 pm Identifying genetic variants with large effects on risk of depression using severe phenotypes DepressionPolygenic risk scorePsychiatric geneticsGenetic epidemiology Poster Fri Oct 23 2:30 pm Predicting diseases of high mortality and morbidity from 4,434 imaging and 99 non-imaging biomarkers in 95,000 UK Biobank participants Artificial intelligenceMathematical modelingMachine learningLarge-scale biobanks Poster Fri Oct 23 2:30 pm Ancestry-specific associations with adult height in 2.1 million diverse exomes Complex traitsExome/genome sequencingRare variantsSkeletal system Talk Sat Oct 24 8:15 am A distinct subset of autoimmune diseases defined by profound co-prevalence and genetic risk association with the IL12 pathway Autoimmune disorderIdentification of disease genesGenome-wide association studyRare variants Session Sat Oct 24 11:15 am 1 invited symposium speaker |
AstraZeneca Cambridge, UK | 1 Senior Data Scientist · 1 Associate Principal Scientist (Centre of Genomics Research) · 1 Associate Principal Scientist · 1 Senior Biostatistician and Data Scientist |
Develops and commercialises prescription medicines for patients across oncology, rare diseases, cardiovascular-renal-metabolic, and respiratory-immunology indications.
| Poster Wed Oct 21 2:30 pm A population-scale assessment of rare long non-coding RNA variants in human disease using ~500,000 UK Biobank whole-genome sequences Rare variantsBioinformaticsNon-coding RNAStatistical genetics Poster Thu Oct 22 4:15 pm Multi-omics non-coding variant prioritization and phenome-wide discovery with JARVIS2 Variant interpretationMachine learningPhenome-wide associationQuantitative trait Poster Thu Oct 22 4:15 pm MILTON v2: Multi-omics and time-to-diagnosis prediction in UK Biobank enhances disease risk stratification and genetic discovery across diverse populations Machine learningLarge-scale biobanksRisk assessmentMulti-omics Poster Thu Oct 22 4:15 pm Coverage-aware exact testing improves calibration and yields more discoveries in a heterogeneous exome cohort Phenome-wide associationStatistical geneticsGenetic testing Poster Fri Oct 23 2:30 pm Genetic determinants of serum alkaline phosphatase in 250,000 longitudinally phenotyped participants suggest novel links to hypophosphatasia symptoms Bone/joint abnormalitiesGenomicsLarge-scale biobanksMendelian disorder |
insitro, inc. South San Francisco, California | 2 Staff Data Scientist · 1 Statistical Geneticist · 1 Scientist I · 1 Scientist |
insitro develops therapeutics and AI discovery platforms using causal human biology, machine learning, and multimodal human and cellular data. Its focus includes metabolic disease, neuroscience, and oncology.
| Poster Wed Oct 21 2:30 pm Multimodal imputation of regional adiposity reveals shared genetic architecture across fat depots and anthropometric traits Genome-wide association studyObesityMetabolic disorder Poster Thu Oct 22 4:15 pm Genetics-guided phenotype imputation increases GWAS power without increasing sample size: age-related macular degeneration as a case study Genome-wide association studyLarge-scale biobanksElectronic health recordsMethodology Poster Thu Oct 22 4:15 pm ML-based MRI phenotyping of supraclavicular fat enables genetic discovery of human brown adipose tissue Deep learningGenome-wide association studyStatistical geneticsPhenotype Poster Thu Oct 22 4:15 pm Druggable genome-scale optical pooled screen paired with single cell-transcriptomics reveal modulators of TDP-43-dependent cryptic exon splicing in human motor neurons Alternative splicingMachine learningMulti-omicsNeurodegeneration Poster Fri Oct 23 2:30 pm ★ Reviewers’ Choice Retinal Imaging AI augments association power for GWAS of age-related macular degenerationArtificial intelligenceComplex diseasesGenome-wide association studyMachine learning |
Eli Lilly and Company Boston, Massachusetts | 1 Senior Advisor, Genomics · 1 PhD Student · 1 Director of Neurodegeneration and Genetic Medicines · 1 Senior Advisor |
Lilly develops and sells prescription medicines for patients across cardiometabolic health, immunology, neuroscience, and cancer.
| Poster Wed Oct 21 2:30 pm Genome-wide association analysis in cognitively unimpaired Alzheimer’s disease reveals novel loci associating with rate of clinical progression in the A4 clinical trial Alzheimer’s diseaseClinical geneticsIdentification of disease genesTranslational studies and preclinical trials Poster Wed Oct 21 2:30 pm Circulating proteomics associated with reductions in liver fat and visceral and subcutaneous adiposity in adults with obesity and MASLD with retatrutide treatment Complex diseasesComplex traitsMetabolic disorderProteomics Poster Thu Oct 22 4:15 pm ★ Reviewers’ Choice Functional characterization of 405 STXBP1 variantsNeurogeneticsVariant interpretationBrain/nervous systemEpilepsy Poster Fri Oct 23 2:30 pm Tirzepatide and semaglutide induce differential plasma proteomic signatures in adults with obesity: an exploratory analysis of SURMOUNT-5 ProteomicsPharmacogenomicsObesityMolecular therapeutics |
deCODE Genetics Reykjavik, IS | 1 Head of Sequence Analysis · 1 Research Scientist · 1 Scientist · 1 Phd Student |
deCODE analyzes human genomes and population data for disease discovery. It develops genomic software and research tools for human genetics.
| Poster Wed Oct 21 2:30 pm The Icelandic pangenome reference BioinformaticsExome/genome sequencingLong-read sequencingNervous system Poster Wed Oct 21 2:30 pm The contribution of genetics to childhood BMI has increased over the last century ObesityStatistical geneticsPolygenic risk scoreGenetic epidemiology Talk Thu Oct 22 8:15 am Association analyses from Oxford Nanopore long read sequenced genomes of UK Biobank participants DatabasesEpigenome-wide association studiesExome/genome sequencingGenomics Poster Thu Oct 22 4:15 pm ★ Reviewers’ Choice Repeat expansions confer dose-dependent protection against cancerCancerCopy number/structural variationGenome-wide association studyLong-read sequencing |
HudsonAlpha Institute for Biotechnology Huntsville, Alabama | 1 PhD Graduate Student · 1 Postdoctoral Researcher · 1 Vice President for Educational Outreach |
HudsonAlpha provides genomic services to researchers, clinicians, and industry leaders. It delivers sequencing, sample preparation, and bioinformatics for human-health and agricultural programs.
| Session Thu Oct 22 11:00 am Talk Thu Oct 22 11:45 am Loss of conserved regulatory elements in human brain evolution Brain/nervous systemEvolutionEvolutionary geneticsGene regulation Poster Thu Oct 22 4:15 pm Poster Fri Oct 23 2:30 pm Mechanisms of SNCA regulation NeurodegenerationNeurogeneticsGene regulationStem cell |
AbbVie St Laurent, Quebec | 1 PhD Student · 1 Senior Scientist · 1 other presenter |
AbbVie discovers and delivers innovative medicines and solutions. It develops therapies for patients across immunology, oncology and neuroscience.
| Talk Thu Oct 22 9:00 am Betanfer: Estimation of linkage disequilibrium from GWAS summary statistics enables large-scale cross-biobank fine mapping Genome-wide association studyGenetic mappingStatistical genetics Poster Thu Oct 22 4:15 pm Omics-driven causal insights into immune-related adverse events in colorectal cancer CancerEpidemiologyImmune systemMulti-omics Poster Fri Oct 23 2:30 pm ★ Reviewers’ Choice Chromatin accessibility dynamics in Lewy body dementia patient-derived fibroblasts reveal disease-specific epigenetic signaturesEpigeneticsNeurodegenerationDifferentiationAlzheimer’s disease |
Pfizer Cambridge, Massachusetts | 1 Associate Director, Translational Medicine Statistics · 1 Statistical Genetics Postdoc |
Pfizer develops and manufactures innovative medicines and vaccines for global healthcare markets.
| Talk Wed Oct 21 1:51 pm Proteomic signatures of lifestyle capture environmental risk and predict incidence of major chronic diseases independently of polygenic risk ProteomicsComplex diseasesPrecision medicineRisk assessment Poster Thu Oct 22 4:15 pm ★ Reviewers’ Choice Proteomic signatures of lifestyle capture environmental risk and predict incidence of major chronic diseases independently of polygenic riskComplex diseasesObesityPrecision medicineProteomics Poster Fri Oct 23 2:30 pm Integrating AlphaMissense predictions and missense variant associations to scale human genetic target evaluation for drug discovery Machine learningGenotype-phenotype correlationsExome/genome sequencingVariant interpretation |
Instantly find 20 buyers from biopharma companies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse ASHG 2026 by
Organization type
Scientific focus
Exhibit hall
Everyone
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction